摘要
目的观察氯沙坦对高血糖合并高血压患者胰岛素敏感性的影响。方法将110例高血糖合并高血压患者随机分为两组,分别接受氨氯地平(HG/A组)和氯沙坦(HG/L组)治疗12周。并将两组患者中代谢综合征(MS)患者分别作为MS/A组和MS/L组。治疗前后分别测定患者的体质指数(BMI)、收缩压(SBP)、舒张压(DBP)、糖化血红蛋白(HbA1c)、空腹血糖(FPG)和空腹胰岛素(FINS)水平,并计算胰岛素抵抗指数(HOMA-IR)。结果 HG/A组和HG/L组患者在经过12周治疗后,SBP和DBP间差别均有统计学意义(P<0.01),且两组患者SBP和DBP降低幅度间差别有统计学意义(P<0.01)。治疗后HG/L组FINS水平和HOMA-IR与HG/A组比较,差别有统计学意义(P<0.01)。治疗后MS/L组患者FINS水平和HOMA-IR与MS/A组比较,差别有统计学意义(P<0.01)。结论高血糖合并高血压患者在经过氯沙坦治疗12周后,不仅血压下降,而且胰岛素敏感性提高;MS患者经氯沙坦治疗12周后胰岛素敏感性也提高。
Objective To investigate the effects of losartan on insulin sensitivity in hyperglycemic patients with hypertension.Methods One hundred ten hyperglycemic patients with hypertension were divided randomly into 2 groups,who were treated with amlodipine(HG/A group) and losartan(HG/L group),respectively,for 12 weeks.Patients with metabolic syndromes were treated with amlodipine(MS/A group),and with losartan(MS/L group).Body mass index(BMI),systolic blood pressure(SBP),diastolic blood pressure(DBP),glycosylated hemoglobin(HbA1c),fasting plasma glucose(FPG),fasting plasma insulin(FINS),total cholesterol(TC) low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C),triglycerides(TG) and homeostasis assessment model of insulin resistance(HOMA-IR)were evaluated before and following treatment.Results After 12 weeks of treatment,SBP and DBP were significantly reduced as compared with baseline in 2 groups(P0.01).FINS and HOMA-IR decreased more in HG/L group than in HG/A group(P0.01).FINS and HOMA-IR reduced more in MS/L group than in MS group(P0.01).Conclusion A 12-week losartan treatment brings about not only a significnat reduction of SBP and DBP but also an improvement of insulin sensitivity in patients with hyperglycosemia with hypertenstion.And insulin sensitivity can also be improved in MS patients.
出处
《临床合理用药杂志》
2011年第04X期20-22,共3页
Chinese Journal of Clinical Rational Drug Use